Alchemi

Alchemi is a software development company operating in the New York City artificial intelligence sector[1]. Founded in 2024, the company develops purpose-built scientific agents designed to accelerate drug development[2]. These agents combine deep scientific expertise with advanced artificial intelligence and are built for GxP environments, streamlining workflows across CMC, bioanalysis, clinical development, and regulatory submissions[2]. According to available information, Alchemi supports more than 3,000 studies and assists life sciences teams in bringing therapies to market[2]. The company has 21 employees[3].

Something wrong or missing? Send a correction. Fixed within 24 hours.